➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Baxter
Harvard Business School
Dow
AstraZeneca

Last Updated: November 25, 2020

DrugPatentWatch Database Preview

Litigation Details for Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Va. 2010)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Pfizer Inc. v. Teva Pharmaceuticals USA, Inc. (E.D. Va. 2010)

Date Filed Document No. Description Snippet Link To Document
2011-03-17 113 the alleged infringement of United States Patent No. 6,469,012 (filed May 13, 1994) (issued…. This patent is different than the '012 patent because the 4012 patent is a method patent for a number… had been previously patented, the '012 patent was unique because it patented sildenafil, along with… v012 patent are invalid and Teva's planned drug will not infringe any patentable claim…Pfizer also holds another patent specifically for sildenafil in United States Patent No. 5,250,534, which External link to document
2010-04-29 19 012 Patent 13. Teva USA admits that according to the face of U.S. Patent No. 6,469,012 (“the…“the ‘012 patent”), the ‘012 patent is titled “Pyrazolopyrimidinones for the Treatment of Impotence,”…that according to the face of the ‘012 patent, the ‘012 patent issued to Pfizer, Inc. as the assignee …the United States Patent and Trademark Office (“PTO”) has reexamined the ‘012 patent, and that claims …matter described in claim 24 of the ‘012 patent is not patentable. Teva USA further admits that what appears External link to document
2010-03-26 3 HOLDER OF PATENT OR TRADEMARK TRADEMARK NO. OR TRADEMARK 1 6,469,012 …action regarding a Patent or Trademark, transmitted to Director of the U.S. Patent and Trademark Office… Industries Ltd. PATENT OR DATE OF PATENT … G Other Pleading PATENT OR DATE OF PATENT …REPORT ON THE TO: Director of the U.S. Patent and Trademark Office FILING External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Merck
Medtronic
Dow
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.